A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
Yokota T, Kato K, Hamamoto Y, Tsubosa Y, Ogawa H, Ito Y, Hara H, Ura T, Kojima T, Chin K, Hironaka S, Kii T, Kojima Y, Akutsu Y, Matsushita H, Kawakami K, Mori K, Makiuchi T, Nagumo R, Kitagawa Y.
Yokota T, et al. Among authors: ogawa h.
Ann Surg Oncol. 2020 Feb;27(2):460-467. doi: 10.1245/s10434-019-07654-8. Epub 2019 Aug 2.
Ann Surg Oncol. 2020.
PMID: 31376034
Clinical Trial.